MariMed Inc. (MRMD)
(Delayed Data from OTC)
$0.11 USD
0.00 (3.81%)
Updated Aug 6, 2025 03:58 PM ET
3-Hold of 5 3
A Value C Growth D Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MRMD 0.11 0.00(3.81%)
Will MRMD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MRMD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MRMD
MariMed Inc. (MRMD) Reports Break-Even Earnings for Q2
MariMed Inc. (MRMD) Reports Q1 Loss, Lags Revenue Estimates
MRMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for MRMD
MariMed Inc Reports Q2 2025 Earnings: EPS at -$0.00, Revenue at $39.6 Million, Misses Estimates
MariMed Reports Second Quarter 2025 Earnings | MRMD Stock News
MariMed Q2 2025 Earnings Preview
MariMed (MRMD) Expands Presence in Pennsylvania Through TILT Partnership